NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib.
Parekh V, Sobanko J, Miller CJ, Karakousis G, Xu W, Letrero R, Elenitsas R, Xu X, Elder DE, Amaravadi R, Schuchter LM, Nathanson KL, Wilson MA, Chu EY.
Parekh V, et al. Among authors: chu ey.
J Cutan Pathol. 2019 Mar;46(3):190-194. doi: 10.1111/cup.13401. Epub 2018 Dec 27.
J Cutan Pathol. 2019.
PMID: 30552700
Free PMC article.